[123i]-Mibg

Iodine (123I) Iobenguane, also known as [123I]-Mibg, is a radiopharmaceutical used in diagnostic imaging for neuroendocrine tumors. This non-invasive scan helps detect abnormalities in the body’s nervous system. It is administered intravenously and provides detailed images for medical evaluation. Short version: [123I]-Mibg is a diagnostic radiopharmaceutical used in imaging neuroendocrine tumors via intravenous administration.

Iodine (123I) Iobenguane is primarily used in diagnostic imaging to identify neuroendocrine tumors, such as pheochromocytomas and neuroblastomas. It may also assist in evaluating other conditions involving the sympathetic nervous system. This radiopharmaceutical helps healthcare providers assess the presence and extent of these tumors. It is not a treatment but a tool for diagnostic purposes.

After administration, Iodine (123I) Iobenguane travels through the bloodstream and accumulates in tissues with sympathetic nervous system activity. The radioactive iodine emits gamma rays, which are detected by a specialized camera to create images. Patients may experience mild discomfort at the injection site or temporary fatigue. The effects are generally short-lived as the radiopharmaceutical is cleared from the body over time.

This radiopharmaceutical should only be handled and administered by trained healthcare professionals in a controlled clinical setting. Patients with known allergies to iodine or previous adverse reactions to similar imaging agents should inform their provider. Pregnant or breastfeeding individuals should avoid this procedure unless medically necessary. Proper hydration is recommended before and after administration to support clearance.

Certain medications, such as tricyclic antidepressants, sympathomimetics, or other drugs affecting the sympathetic nervous system, may interfere with the imaging results. Patients should disclose all current medications to their healthcare provider prior to the procedure. Alcohol and caffeine consumption may also impact imaging quality and should be avoided as directed. No known direct drug interactions with Iodine (123I) Iobenguane itself have been reported.